Avantor Q2 earnings exceeded estimates, revenue reached $1.70bn, and institutional investors increased stakes.
Avantor, Inc. (NYSE: AVTR) experienced a 7.6% reduction in shares held by Forsta AP Fonden in Q2, while other institutional investors increased their stakes. The company reported Q2 earnings of $0.25 per share, exceeding estimates, with revenues of $1.70 billion. Analysts maintain a "Moderate Buy" rating for Avantor, with an average price target of $27.40. The firm serves various sectors, including biopharma and healthcare.
September 16, 2024
3 Articles